These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9511930)

  • 1. Probing the structural and functional domains of the CFTR chloride channel.
    Akabas MH; Cheung M; Guinamard R
    J Bioenerg Biomembr; 1997 Oct; 29(5):453-63. PubMed ID: 9511930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Channel-lining residues in the M3 membrane-spanning segment of the cystic fibrosis transmembrane conductance regulator.
    Akabas MH
    Biochemistry; 1998 Sep; 37(35):12233-40. PubMed ID: 9724537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of cystic fibrosis transmembrane conductance regulator channel-lining residues in and flanking the M6 membrane-spanning segment.
    Cheung M; Akabas MH
    Biophys J; 1996 Jun; 70(6):2688-95. PubMed ID: 8744306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locating the anion-selectivity filter of the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel.
    Cheung M; Akabas MH
    J Gen Physiol; 1997 Mar; 109(3):289-99. PubMed ID: 9089437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of proline residues in the membrane-spanning domains of cystic fibrosis transmembrane conductance regulator to chloride channel function.
    Sheppard DN; Travis SM; Ishihara H; Welsh MJ
    J Biol Chem; 1996 Jun; 271(25):14995-5001. PubMed ID: 8663008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chloride channel and chloride conductance regulator domains of CFTR, the cystic fibrosis transmembrane conductance regulator.
    Schwiebert EM; Morales MM; Devidas S; Egan ME; Guggino WB
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2674-9. PubMed ID: 9482946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permeation through the CFTR chloride channel.
    McCarty NA
    J Exp Biol; 2000 Jul; 203(Pt 13):1947-62. PubMed ID: 10851114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pharmacology of the CFTR Cl- channel.
    Hwang TC; Sheppard DN
    Trends Pharmacol Sci; 1999 Nov; 20(11):448-53. PubMed ID: 10542444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acid residues lining the chloride channel of the cystic fibrosis transmembrane conductance regulator.
    Akabas MH; Kaufmann C; Cook TA; Archdeacon P
    J Biol Chem; 1994 May; 269(21):14865-8. PubMed ID: 7515047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular determinants of anion selectivity in the cystic fibrosis transmembrane conductance regulator chloride channel pore.
    Linsdell P; Evagelidis A; Hanrahan JW
    Biophys J; 2000 Jun; 78(6):2973-82. PubMed ID: 10827976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional roles of nonconserved structural segments in CFTR's NH2-terminal nucleotide binding domain.
    Csanády L; Chan KW; Nairn AC; Gadsby DC
    J Gen Physiol; 2005 Jan; 125(1):43-55. PubMed ID: 15596536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable dimeric assembly of the second membrane-spanning domain of CFTR (cystic fibrosis transmembrane conductance regulator) reconstitutes a chloride-selective pore.
    Ramjeesingh M; Ugwu F; Li C; Dhani S; Huan LJ; Wang Y; Bear CE
    Biochem J; 2003 Nov; 375(Pt 3):633-41. PubMed ID: 12892562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cystic fibrosis transmembrane conductance regulator phenylalanine 508 side chain in ion channel gating.
    Cui L; Aleksandrov L; Hou YX; Gentzsch M; Chen JH; Riordan JR; Aleksandrov AA
    J Physiol; 2006 Apr; 572(Pt 2):347-58. PubMed ID: 16484308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of the C-terminal boundary of the second nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator and structural implications.
    Gentzsch M; Aleksandrov A; Aleksandrov L; Riordan JR
    Biochem J; 2002 Sep; 366(Pt 2):541-8. PubMed ID: 12020354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmembrane domain of cystic fibrosis transmembrane conductance regulator: design, characterization, and secondary structure of synthetic peptides m1-m6.
    Wigley WC; Vijayakumar S; Jones JD; Slaughter C; Thomas PJ
    Biochemistry; 1998 Jan; 37(3):844-53. PubMed ID: 9454574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the putative pore-forming domain of CFTR do not change anion selectivity of the cAMP activated Cl- conductance.
    Hipper A; Mall M; Greger R; Kunzelmann K
    FEBS Lett; 1995 Nov; 374(3):312-6. PubMed ID: 7589561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of an ion channel-forming motif in the primary structure of CFTR, the cystic fibrosis chloride channel.
    Oblatt-Montal M; Reddy GL; Iwamoto T; Tomich JM; Montal M
    Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1495-9. PubMed ID: 7509074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revisiting cystic fibrosis transmembrane conductance regulator structure and function.
    Hanrahan JW; Wioland MA
    Proc Am Thorac Soc; 2004; 1(1):17-21. PubMed ID: 16113406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular models of the open and closed states of the whole human CFTR protein.
    Mornon JP; Lehn P; Callebaut I
    Cell Mol Life Sci; 2009 Nov; 66(21):3469-86. PubMed ID: 19707853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of the CFTR channel's gates.
    Vergani P; Basso C; Mense M; Nairn AC; Gadsby DC
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1003-7. PubMed ID: 16246032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.